Suchen Sie nach Informationen zu Eusa Pharma-Hauptsitz? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.
Keep up to date with our latest news and developments. On 16 March 2022, EUSA Pharma (UK) Ltd. was acquired by Recordati, an international pharmaceutical group listed on the Italian Stock Exchange (ISIN IT 0003828271), with a total staff of more than 4,300, dedicated to the research, development, manufacturing and marketing of pharmaceuticals.
https://www.dnb.com/business-directory/company-profiles.eusa_pharma_(us)_llc.739a831019ee2ff9ffaae7bffe56fac0.html
Company Description: Eusa Pharma (us) LLC is located in Burlington, MA, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry. Eusa Pharma (us) LLC has 12 total employees across all of its locations and generates $1.13 million in sales (USD). (Sales figure is modelled).
https://www.dnb.com/business-directory/company-profiles.eusa_pharma_(usa)_inc.5639a3a31ece6c867f447389588a0a04.html
Pharmaceutical and Medicine Manufacturing Chemical Manufacturing Manufacturing Printer Friendly View Address: 1717 Langhorne Newtown Rd Ste 201 Langhorne, PA, 19047-1085 United States See other locations
https://craft.co/eusa-pharma
EUSA Pharma is a biopharmaceutical company focused on oncology and rare diseases. It offers Sylvant, a product for the treatment of patients with idiopathic multicentric Castleman’s disease (MCD). The company also provides Qarziba for the treatment of high-risk neuroblastoma and Fotivda for the first-line treatment of adult patients with ...
https://www.bloomberg.com/profile/company/1469106D:US
Eusa Pharma US LLC. Eusa Pharma (US) LLC was founded in 2015. The company's line of business includes the wholesale distribution of surgical and other medical instruments, apparatus, and equipment.
Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Eusa Pharma-Hauptsitz gefunden haben.
